Higher BMI in mothers before pregnancy is associated with shorter telomere length - a biomarker for biological age - in newborns, according to a study published in the open access journal BMC Medicine that involved 743 mothers and their babies. The study by researchers at Hasselt University, Belgium is the first to report a strong association between mothers' BMI and telomere length in newborns.
Telomeres are structures at the ends of chromosomes which are vital in maintaining the stability of a person's genome as they protect chromosomes from degradation. Telomere length, which is measured by the number of DNA base pairs they occupy, is directly linked to the number of times a cell can divide in its lifetime. Thus, longer telomeres allow cells to divide more often, providing a link between telomere length and biological age. Telomere length in adults has been associated with age-related diseases such as cardiovascular disease, type 2 diabetes and increased mortality, but telomere research on newborns remains limited.
Professor Tim Nawrot, the corresponding author, said: "Compared with newborns of mothers with a normal BMI, newborns of women with obesity are older on a molecular level, because shortened telomere lengths mean that their cells have shorter lifespans. So maintaining a healthy BMI during a woman's reproductive age may promote molecular longevity in the offspring."
Previous studies have shown that people normally lose about 32.2 to 45.5 telomere base pairs per year in adulthood. The research team found that for each one-point increase in the mothers' BMI, telomeres in the babies were about 50 base pairs shorter. According to the researchers, this 50 base pair shortening of telomere length is equivalent to the length that people normally lose in 1.1 - 1.6 years of adult life, which may increase the risk of chronic diseases in adulthood.
Dries Martens, co-author of the paper, said: "We ruled out many other potential factors that may be associated with telomere length, including parents' age at birth, socio-economic class, ethnicity, maternal smoking status, newborns' gender or birth weight."
Professor Nawrot said: "Prior to our study, there was no evidence of an association between pre-pregnancy BMI and newborn telomere length, although meta-analyses suggest an association between BMI and telomere length in adults. Our results add to the growing body of evidence that high maternal BMI impacts fetal programming, which could lead to altered fetal development and later life diseases. The public health impact of our findings is considerable as in affluent societies about 30% of women of reproductive age are overweight."
To examine associations between maternal BMI and newborn telomere length, Nawrot and Martens examined 743 mothers, who were 17 to 44 years of age, and their newborn babies. Detailed information on maternal and paternal age, socioeconomic status, smoking status, parity, ethnicity and pregnancy complications was obtained by use of a questionnaire. To measure average telomere lengths, umbilical cord blood was drawn immediately after delivery from all 743 mother-newborn pairs.
The researchers say that their study may be limited by lack of information on paternal BMI as previous research has described epigenetic effects of paternal weight on newborns.
Junior Press Officer
T: +44 (0)20 3192 2054
1. Maternal pre-pregnancy body mass index and newborn telomere length
Dries S. Martens, Michelle Plusquin, Wilfried Gyselaers, Immaculata De Vivo and Tim S. Nawrot, BMC Medicine 2016
DOI: DOI 10.1186/s12916-016-0689-0
During the embargo period, please contact Alanna Orpen for a copy of the article.
After the embargo lifts, the article will be available at the journal website here: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0689-0
Please name the journal in any story you write. If you are writing for the web, please link to the article. All articles are available free of charge, according to BioMed Central's open access policy.
2. BMC Medicine is an open access, open peer-reviewed general medical journal publishing outstanding and influential research in all areas of clinical practice, translational medicine, public health, policy, and general topics of interest to the biomedical research community. As the flagship medical journal of the BMC series, we also publish stimulating debates and reviews as well as unique forum articles and concise tutorials.
3. BioMed Central is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Nature, a major new force in scientific, scholarly, professional and educational publishing, created in May 2015 through the combination of Nature Publishing Group, Palgrave Macmillan, Macmillan Education and Springer Science+Business Media. http://www.biomedcentral.com